Morning increase of onset of myocardial infarction. Implications concerning triggering events

J E Muller1

  • 1Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02115.

Cardiology
|January 1, 1989
PubMed

Insights

Acute myocardial infarction and related cardiovascular events show a notable morning increase. This highlights the need for morning pharmacologic protection and understanding patient activities in triggering coronary thrombosis.

Area of Science:

  • Cardiology
  • Circadian Rhythms
  • Thrombosis

Background:

  • Established evidence shows a prominent morning increase in acute myocardial infarction (AMI) onset.
  • Similar morning peaks are observed for sudden cardiac death, stroke, and transient myocardial ischemia.
  • Physiologic changes in the morning, including increased arterial pressure, coronary tone, and platelet aggregability, may contribute to coronary thrombosis.

Purpose of the Study:

  • To emphasize the importance of morning pharmacologic protection for patients at risk.
  • To explore the concept that patient activities may trigger coronary thrombosis onset throughout the day.
  • To facilitate the design of more effective preventive therapies for cardiovascular disease.

Main Methods:

  • Review of established scientific literature on the timing of cardiovascular events.
  • Analysis of physiological changes occurring in the morning hours.
  • Conceptual framework development linking patient activities to thrombosis onset.

Main Results:

  • Consistent observation of increased frequency of AMI, sudden cardiac death, stroke, and transient myocardial ischemia in the morning hours (6 a.m. to noon).
  • Identification of intensified physiological processes during this period, including elevated arterial pressure, coronary tone, and platelet aggregability.
  • Recognition that daily patient activities may be triggers for coronary thrombosis.

Conclusions:

  • Pharmacologic interventions should prioritize morning hours for patients susceptible to cardiovascular events.
  • Understanding the role of patient activities in triggering coronary thrombosis is crucial for long-term prevention.
  • Further investigation into activity-related triggers can improve therapeutic strategies for cardiovascular disease onset.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...